Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Jul 13, 2020 12:38pm

227 Views

Post# 31260969

RE:RE:How Did It Ever Go From

Quattro74 wrote:

toade1313 wrote: ...'The Greatest Story Never Told' to 'The Greatest Promise Never Delivered'?

I'll agree with this once the FT designation comes out, Phase 2 data comes and is like phase 1 data, US sites start to recruit/treat. And we are still at .23c

Looks like we could have restaurants and bars opened up before the trial will start again. Makes sense, the wife needs to be able to go somewhere while she is waiting for her hubby to have his PDT procedure.
Macer

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload